Products
Platform
Research
Market
Learn
Compare Mirae Asset Healthcare Fund vs UTI Healthcare Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹99 | ₹500 |
Expense Ratio | 1.93 | 2.26 |
NAV | ₹38.30 | ₹287.25 |
Fund Started | 11 Jun 2018 | 01 Aug 2005 |
Fund Size | ₹2812.12 Cr | ₹1126.13 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year. | Exit load of 1% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹99
₹500
Expense Ratio
1.93
2.26
NAV
₹38.30
₹287.25
Fund Started
11 Jun 2018
01 Aug 2005
Fund Size
₹2812.12 Cr
₹1126.13 Cr
Exit Load
Exit load of 1% if redeemed within 1 year.
Exit load of 1% if redeemed within 30 days.
Returns
1 Year | -0.18% | -1.23% |
3 Year | 20.77% | 23.83% |
5 Year | 15.92% | 15.73% |
1 Year
-0.18%
-1.23%
3 Year
20.77%
23.83%
5 Year
15.92%
15.73%
Holding Analysis
Equity | 99.31% | 98.75% |
Cash | 0.69% | 1.24% |
Equity
99.31%
98.75%
Cash
0.69%
1.24%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.01% |
Divi's Laboratories Ltd. | 8.88% |
Glenmark Pharmaceuticals Ltd. | 6.41% |
Apollo Hospitals Enterprise Ltd. | 6.21% |
Cipla Ltd. | 5.42% |
Lupin Ltd. | 5.07% |
Fortis Healthcare Ltd. | 4.33% |
Aurobindo Pharma Ltd. | 4.09% |
Dr. Reddy's Laboratories Ltd. | 4.02% |
Krishna Institute of Medical Sciences Ltd | 3.77% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.76% |
Ajanta Pharma Ltd. | 6.48% |
Lupin Ltd. | 5.91% |
Glenmark Pharmaceuticals Ltd. | 4.06% |
Dr. Reddy's Laboratories Ltd. | 3.74% |
Gland Pharma Ltd. | 3.46% |
Apollo Hospitals Enterprise Ltd. | 3.45% |
Alkem Laboratories Ltd. | 3.43% |
Procter & Gamble Health Ltd. | 3.41% |
Cipla Ltd. | 3.40% |
Fund Manager
Name | Vrijesh Kasera | Kamal Gada |
Start Date | 03 Feb 2023 | 02 May 2022 |
Name
Vrijesh Kasera
Kamal Gada
Start Date
03 Feb 2023
02 May 2022
About Fund
Description | The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. |
Launch Date | 11 Jun 2018 | 01 Aug 2005 |
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
11 Jun 2018
01 Aug 2005